|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000163820 |
Summary for FYCO1 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000163820 | Gene symbol | FYCO1 |
| Gene name | FYVE and coiled-coil domain autophagy adaptor 1 | |
| HGNC | 14673 | |
| Entrez ID | 79443 | |
| Gene type | protein_coding | |
| Synonyms | FYCO1|FLJ13335|ZFYVE7 | |
| UniProtAcc | Q9BQS8 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for FYCO1 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| FYCO1 | 1.57e+03 | -1.21e+00 | 1.43e-01 | -8.49e+00 | 2.07e-17 | 3.19e-16 | COAD |
| FYCO1 | 4.99e+03 | -1.59e+00 | 2.46e-01 | -6.48e+00 | 9.26e-11 | 1.03e-08 | ESCA |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| FYCO1 | 1.74e+03 | -1.37e+00 | 2.58e-01 | -5.31e+00 | 1.12e-07 | 1.28e-06 | READ |
Top |
Sex-biased somatic mutation for FYCO1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for FYCO1 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| ACC | cg24208206 | chr3:45995079 | CGI:chr3:45995521-45995981 | promoter,gene body | 2.34e-01 | 3.59e-01 | -2.39e+00 | 1.69e-02 | 3.29e-02 | -1.25e-01 |
| KICH | cg16042668 | chr3:45996100 | CGI:chr3:45995521-45995981 | promoter | 4.84e-01 | 3.83e-01 | 2.14e+00 | 3.22e-02 | 4.37e-02 | 1.01e-01 |
| DLBC | cg16042668 | chr3:45996100 | CGI:chr3:45995521-45995981 | promoter | 2.72e-01 | 4.01e-01 | -2.63e+00 | 8.59e-03 | 2.04e-02 | -1.29e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BLCA | cg18682028 | chr3:45993947 | CGI:chr3:45995521-45995981 | promoter,gene body | 7.68e-01 | 8.95e-01 | -2.61e+00 | 8.97e-03 | 1.30e-02 | -1.27e-01 |
| BLCA | cg16042668 | chr3:45996100 | CGI:chr3:45995521-45995981 | promoter | 2.14e-01 | 3.67e-01 | -3.87e+00 | 1.09e-04 | 4.27e-04 | -1.53e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg18682028 | chr3:45993947 | CGI:chr3:45995521-45995981 | promoter,gene body | 7.18e-01 | 8.97e-01 | -7.78e+00 | 7.20e-15 | 2.60e-14 | -1.80e-01 |
Top |
Exon skipping events with PSI in TCGA for FYCO1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for FYCO1 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for FYCO1 |
TFs related to FYCO1.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BLCA | GLI4 | FYCO1 | 4.15e+00 | 9.83e-01 | 3.12e+00 | 4.31e-03 | Male-biased |
| BLCA | INSM1 | FYCO1 | 3.96e+00 | 9.81e-01 | 2.47e+00 | 9.49e-04 | Male-biased |
| BLCA | MNT | FYCO1 | 4.35e+00 | 9.81e-01 | 3.55e+00 | 9.90e-03 | Male-biased |
| BLCA | NFIA | FYCO1 | 4.65e+00 | 9.87e-01 | 3.80e+00 | 8.30e-03 | Male-biased |
| BLCA | NFIB | FYCO1 | 4.65e+00 | 9.86e-01 | 3.81e+00 | 8.88e-03 | Male-biased |
| BLCA | PLAGL2 | FYCO1 | 3.96e+00 | 9.82e-01 | 1.99e+00 | 1.62e-04 | Male-biased |
| BLCA | POU6F2 | FYCO1 | 4.41e+00 | 1.29e-03 | 5.79e+00 | 9.98e-01 | Female-biased |
| BLCA | SIX5 | FYCO1 | 3.55e+00 | 5.21e-03 | 4.56e+00 | 9.88e-01 | Female-biased |
| BLCA | TFAP2B | FYCO1 | 4.15e+00 | 9.87e-01 | 2.48e+00 | 5.21e-04 | Male-biased |
| BLCA | TFAP2C | FYCO1 | 4.03e+00 | 9.84e-01 | 2.49e+00 | 7.86e-04 | Male-biased |
| BLCA | TFAP4 | FYCO1 | 3.96e+00 | 9.81e-01 | 2.63e+00 | 1.57e-03 | Male-biased |
| BLCA | ZNF223 | FYCO1 | 4.00e+00 | 9.80e-01 | 2.87e+00 | 3.07e-03 | Male-biased |
| BLCA | ZNF324B | FYCO1 | 4.17e+00 | 9.83e-01 | 3.21e+00 | 5.50e-03 | Male-biased |
| BLCA | ZNF331 | FYCO1 | 3.98e+00 | 9.83e-01 | 2.22e+00 | 3.70e-04 | Male-biased |
| BLCA | ZNF419 | FYCO1 | 4.00e+00 | 9.82e-01 | 2.66e+00 | 1.53e-03 | Male-biased |
| BLCA | ZNF605 | FYCO1 | 3.95e+00 | 9.82e-01 | 2.24e+00 | 4.46e-04 | Male-biased |
| BLCA | ZNF674 | FYCO1 | 4.02e+00 | 9.82e-01 | 2.76e+00 | 2.03e-03 | Male-biased |
| BLCA | ZNF677 | FYCO1 | 3.73e+00 | 1.00e-02 | 4.59e+00 | 9.83e-01 | Female-biased |
| BLCA | ZNF692 | FYCO1 | 3.91e+00 | 9.80e-01 | 2.07e+00 | 2.76e-04 | Male-biased |
| BLCA | ZNF749 | FYCO1 | 4.27e+00 | 9.82e-01 | 3.40e+00 | 7.66e-03 | Male-biased |
| CHOL | POU6F2 | FYCO1 | 4.88e+00 | 1.49e-02 | 5.72e+00 | 9.84e-01 | Female-biased |
| DLBC | POU6F2 | FYCO1 | 5.27e+00 | 9.82e-01 | 4.53e+00 | 1.64e-02 | Male-biased |
| ESCA | HNF4G | FYCO1 | 4.22e+00 | 9.85e-01 | 3.42e+00 | 6.50e-03 | Male-biased |
| ESCA | TFAP2B | FYCO1 | 4.15e+00 | 9.85e-01 | 3.33e+00 | 5.61e-03 | Male-biased |
| ESCA | TFAP2C | FYCO1 | 4.08e+00 | 9.83e-01 | 3.28e+00 | 6.48e-03 | Male-biased |
| ESCA | TFE3 | FYCO1 | 4.75e+00 | 9.82e-01 | 4.09e+00 | 1.41e-02 | Male-biased |
| READ | POU6F2 | FYCO1 | 4.71e+00 | 1.71e-02 | 5.42e+00 | 9.81e-01 | Female-biased |
| SKCM | INSM1 | FYCO1 | 3.13e+00 | 4.11e-03 | 4.39e+00 | 9.80e-01 | Female-biased |
| SKCM | NHLH2 | FYCO1 | 3.22e+00 | 4.61e-03 | 4.44e+00 | 9.81e-01 | Female-biased |
| SKCM | PLAGL2 | FYCO1 | 2.99e+00 | 9.82e-04 | 4.67e+00 | 9.88e-01 | Female-biased |
| SKCM | POU6F2 | FYCO1 | 4.79e+00 | 9.87e-01 | 3.52e+00 | 5.13e-03 | Male-biased |
| SKCM | SNAI1 | FYCO1 | 3.07e+00 | 2.48e-03 | 4.48e+00 | 9.84e-01 | Female-biased |
| SKCM | ZNF320 | FYCO1 | 3.21e+00 | 4.71e-03 | 4.42e+00 | 9.80e-01 | Female-biased |
| SKCM | ZNF331 | FYCO1 | 3.36e+00 | 4.28e-03 | 4.61e+00 | 9.84e-01 | Female-biased |
| SKCM | ZNF605 | FYCO1 | 3.02e+00 | 1.90e-03 | 4.51e+00 | 9.85e-01 | Female-biased |
| SKCM | ZNF692 | FYCO1 | 3.21e+00 | 2.12e-03 | 4.68e+00 | 9.87e-01 | Female-biased |
| THYM | POU6F2 | FYCO1 | 5.92e+00 | 9.91e-01 | 5.19e+00 | 8.06e-03 | Male-biased |
FYCO1 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for FYCO1 |
RBPs related to ES in FYCO1.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| LUSC | SAMD4A | exon_skip_382826 | 8.38e+00 | 9.89e-01 | 7.90e+00 | 3.61e-03 | Male-biased |
| THCA | SAMD4A | exon_skip_382824 | 6.66e+00 | 9.83e-01 | 6.14e+00 | 5.14e-04 | Male-biased |
| THCA | SAMD4A | exon_skip_382826 | 8.30e+00 | 1.04e-02 | 8.59e+00 | 9.84e-01 | Female-biased |
| KICH | SAMD4A | exon_skip_382826 | 8.32e+00 | 5.27e-03 | 8.70e+00 | 9.89e-01 | Female-biased |
FYCO1 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs74786716 | chr3:37527236:A:G | - | 0.244911137210546 | 0.00698440053450526 | PCPG | Female-baised eQTL |
| rs77820597 | chr3:37527286:G:A | - | 0.244911137210546 | 0.00698440053450526 | PCPG | Female-baised eQTL |
| rs3733140 | chr3:37519474:C:A | - | 0.242676615841792 | 0.0086219504570783 | PCPG | Female-baised eQTL |
| rs75619156 | chr3:37523362:C:T | - | 0.242676615841792 | 0.0086219504570783 | PCPG | Female-baised eQTL |
| rs17229924 | chr3:37525542:A:G | - | 0.242676615841792 | 0.0086219504570783 | PCPG | Female-baised eQTL |
| rs78544469 | chr3:37507289:T:C | - | 0.223209886790239 | 0.0172672046878932 | PCPG | Female-baised eQTL |
| rs77422813 | chr3:37507911:C:T | - | 0.223209886790239 | 0.0172672046878932 | PCPG | Female-baised eQTL |
| rs17228684 | chr3:37508492:G:A | - | 0.223209886790239 | 0.0172672046878932 | PCPG | Female-baised eQTL |
| rs75425697 | chr3:37509832:A:G | - | 0.223209886790239 | 0.0172672046878932 | PCPG | Female-baised eQTL |
| rs12054441 | chr3:37517990:T:C | - | 0.223209886790239 | 0.0172672046878932 | PCPG | Female-baised eQTL |
| rs74985154 | chr3:37518623:A:T | - | 0.223209886790239 | 0.0172672046878932 | PCPG | Female-baised eQTL |
| rs3733138 | chr3:37519217:A:G | - | 0.223209886790239 | 0.0172672046878932 | PCPG | Female-baised eQTL |
| rs17814364 | chr3:37496147:G:A | - | 0.227551653142818 | 0.0280760736268216 | PCPG | Female-baised eQTL |
| rs112038297 | chr3:37500743:G:A | - | 0.227551653142818 | 0.0280760736268216 | PCPG | Female-baised eQTL |
| rs7644969 | chr3:51876286:T:G | - | -0.111816418160196 | 0.0174300236497363 | KIRC | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs73078617 | chr3:51330551:A:G | - | 0.135593626291407 | 2.00744691090298e-06 | KIRC | Male-baised eQTL |
| rs73080658 | chr3:51724804:C:T | - | 0.108511078726444 | 9.28025900604405e-05 | KIRC | Male-baised eQTL |
| rs73075542 | chr3:46599499:A:G | - | 0.1004749691693 | 9.53490394395107e-05 | KIRC | Male-baised eQTL |
| rs56052360 | chr3:51241345:C:T | - | 0.112525858265777 | 9.73606605321777e-05 | KIRC | Male-baised eQTL |
| rs56372008 | chr3:51279478:A:G | - | 0.112399977209331 | 0.000100111015503002 | KIRC | Male-baised eQTL |
| rs73075538 | chr3:46599292:T:C | - | 0.100267020550481 | 0.000101887267686425 | KIRC | Male-baised eQTL |
| rs73075539 | chr3:46599307:C:A | - | 0.100267020550481 | 0.000101887267686425 | KIRC | Male-baised eQTL |
| rs685887 | chr3:50639624:C:A | - | 0.0810389690193531 | 0.0177820306838497 | KIRC | Male-baised eQTL |
| rs1449995 | chr3:36120363:A:T | - | 0.0470041046431451 | 0.0266159596332923 | KIRC | Male-baised eQTL |
| rs1479151 | chr3:36302987:G:A | - | 0.0451662333419936 | 0.0448911647387897 | KIRC | Male-baised eQTL |
| rs9855152 | chr3:44417238:T:C | - | -0.0361676546542695 | 0.0209253439777003 | BLCA | Male-baised eQTL |
| rs9845909 | chr3:44419251:C:T | - | -0.0356058083528925 | 0.0238387239030648 | BLCA | Male-baised eQTL |
| rs9865920 | chr3:44419338:T:C | - | -0.0352421917741416 | 0.0266234747912512 | BLCA | Male-baised eQTL |
| rs9846407 | chr3:44419546:C:T | - | -0.0352421917741416 | 0.0266234747912512 | BLCA | Male-baised eQTL |
| rs9813415 | chr3:44420250:A:G | - | -0.0352421917741416 | 0.0266234747912512 | BLCA | Male-baised eQTL |
| rs9876127 | chr3:44421105:T:G | - | -0.0352421917741416 | 0.0266234747912512 | BLCA | Male-baised eQTL |
| rs12054231 | chr3:44423127:T:C | - | -0.0352421917741416 | 0.0266234747912512 | BLCA | Male-baised eQTL |
| rs1632166 | chr3:39483052:T:C | - | -0.0382080446571342 | 0.0275491026378073 | BLCA | Male-baised eQTL |
| rs1707956 | chr3:39482025:C:T | - | -0.0378379287574454 | 0.0293032335772725 | BLCA | Male-baised eQTL |
| rs1398666 | chr3:39475540:C:T | - | -0.0376734771546414 | 0.0314520011390133 | BLCA | Male-baised eQTL |
| rs1768202 | chr3:39476053:A:G | - | -0.0376734771546414 | 0.0314520011390133 | BLCA | Male-baised eQTL |
| rs481523 | chr3:39477849:T:A | - | -0.0376734771546414 | 0.0314520011390133 | BLCA | Male-baised eQTL |
| rs13096846 | chr3:44184081:T:A | - | 0.0751139999484716 | 0.0329059735347025 | BLCA | Male-baised eQTL |
| rs3935211 | chr3:44419511:G:A | - | -0.0342563843998118 | 0.0337589669174774 | BLCA | Male-baised eQTL |
| rs3935210 | chr3:44419588:G:A | - | -0.0342563843998118 | 0.0337589669174774 | BLCA | Male-baised eQTL |
| rs6790261 | chr3:44422156:C:T | - | -0.0342563843998118 | 0.0337589669174774 | BLCA | Male-baised eQTL |
| rs6790566 | chr3:44422443:C:A | - | -0.0342563843998118 | 0.0337589669174774 | BLCA | Male-baised eQTL |
| rs9862508 | chr3:44422626:C:A | - | -0.0342563843998118 | 0.0337589669174774 | BLCA | Male-baised eQTL |
| rs6599028 | chr3:39492344:G:C | - | -0.0363889776891213 | 0.0369724093073319 | BLCA | Male-baised eQTL |
| rs604869 | chr3:39486307:G:A | - | -0.03632853455945 | 0.0379811202139682 | BLCA | Male-baised eQTL |
| rs1768149 | chr3:39466089:T:C | - | -0.0365342064159451 | 0.0397626923133905 | BLCA | Male-baised eQTL |
| rs1707943 | chr3:39487584:T:C | - | -0.0361200501859954 | 0.0398418872323326 | BLCA | Male-baised eQTL |
| rs1768215 | chr3:39487684:T:C | - | -0.0361200501859954 | 0.0398418872323326 | BLCA | Male-baised eQTL |
| rs614823 | chr3:39493267:A:G | - | -0.0361200501859954 | 0.0398418872323326 | BLCA | Male-baised eQTL |
| rs67253985 | chr3:44510851:A:C | - | 0.0337659899333916 | 0.0420389660912852 | BLCA | Male-baised eQTL |
| rs4334678 | chr3:44523333:G:A | - | 0.0337659899333916 | 0.0420389660912852 | BLCA | Male-baised eQTL |
| rs71615429 | chr3:44526831:C:T | - | 0.0337659899333916 | 0.0420389660912852 | BLCA | Male-baised eQTL |
| rs1707944 | chr3:39487141:G:A | - | -0.0354830167106962 | 0.0483869928734322 | BLCA | Male-baised eQTL |
| rs13072696 | chr3:44527328:G:A | - | 0.033321451287395 | 0.0487437429205535 | BLCA | Male-baised eQTL |
| rs4610267 | chr3:44444422:T:C | - | -0.0322549076716026 | 0.0489846221837435 | BLCA | Male-baised eQTL |
| rs13100967 | chr3:44534949:C:T | - | 0.0332355138356153 | 0.0492468555544974 | BLCA | Male-baised eQTL |
| rs13058792 | chr3:44534983:G:A | - | 0.0332355138356153 | 0.0492468555544974 | BLCA | Male-baised eQTL |
| rs13081128 | chr3:44535051:T:C | - | 0.0332355138356153 | 0.0492468555544974 | BLCA | Male-baised eQTL |
| rs9311357 | chr3:44456109:G:A | - | -0.0319929726339126 | 0.049528797211356 | BLCA | Male-baised eQTL |
| rs55704305 | chr3:44422841:G:A | - | -0.0330469633886725 | 0.0495750565695841 | BLCA | Male-baised eQTL |
| rs1373886 | chr3:55720974:A:G | - | 0.0579605741014204 | 0.0465489459872119 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg16320329 | chr3:45939669 | gene | -0.434620265744974 | 9.09649541915522e-19 | -0.6003605907651101 | 4.523500089380118e-21 | KIRP |
| cg08033130 | chr3:45942105 | gene | -0.434620265744974 | 9.09649541915522e-19 | -0.6003605907651101 | 4.523500089380118e-21 | KIRP |
| cg18004856 | chr3:45987786 | gene | -0.434620265744974 | 9.09649541915522e-19 | -0.6003605907651101 | 4.523500089380118e-21 | KIRP |
| cg19145607 | chr3:45942300 | gene | -0.191936431362483 | 5.71623337983499e-06 | -0.3707210613326118 | 6.047938059111443e-08 | KIRP |
| cg16320329 | chr3:45939669 | gene | -0.304532126888199 | 8.09448767206396e-09 | -0.453953071013381 | 6.430849211641262e-12 | KIRC |
| cg11211486 | chr3:45992308 | gene | -0.373963605612071 | 2.11908147143978e-06 | -0.3969519649911356 | 2.052293753888913e-09 | KIRC |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of FYCO1 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000163820 | FYCO1 | C1864908 | Cataract, autosomal recessive congenital 2 | 1 | CTD_human |